1Unwin N,Shaw J, Zimmet P. International Diabetes Federation IGF/IGT consensus statement. Impaired glucose tolerance and impaired fadting glycaemia: The current status on definition and intervention[J]. Diabetic Med, 2002,19: 708 - 723.
2Grundy S N, Reeker D, Clark L T, et al. National cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adult Treatment Panel Ⅲ ) [J]. JAMA, 2001,285: 2486 - 2497.
3Looker H C, Knowler W C, Hanson R L. Changes in BMI and weight before and after the development of type 2 diabetes [J]. Diabetes Care,2001,24:1917 - 1923.
4Klewer S A, Xu H E, Lambert M H, et al. Peroxisome proliferatoractivated receptors: From genes to physiology[J]. Recent Prog Horm Res, 2001,56: 239 - 263.
5Hammarstedt A, Smith U. PPAR gamma, but not PPAR alpha, ligands increase IRS- 1 gene and protein expression in L6 muscle cells[J]. Diabetes, 2001,50: A409.
6HOPE Research Group. Angiotensin converting engyme inhibitor- effect of ramipril on cardiovascular events in high risk patients[J]. N Engl J Med,2000,342:311 - 316.
7American Diabetes Association. Screening for diabetes [J]. Diabetes Care, 2002,25 (suppl1): 21 - 24.
8Narayan K M V, Imperatore G, Benjamin S M, et al. Targting people with pre - diabetes[J]. BMJ, 2002,325: 403 - 404.
9Yip I, Go V L, Hershman J M, et al. Insulin- leptin - visceral fat relation during weight loss[J]. Pancreas,2001,23:197 - 203.
10Maclean P S, Zheng D, Dohm G L. Muscle glucose transporter (GLUT4) gene expression during exercise [J]. Exerc Sport Sci Rev,2001,28:148 - 152.
